Centinel Spine recently announced achievement of record revenue in the third quarter of 2024—outperforming Q2 2024, its previous record quarter.
Centinel Spine remains one of the fastest growing companies in the spine industry.*
Third Quarter 2024 Highlights
- Record worldwide prodisc TDR revenue of approximately $22.5 million, representing 30% year-over-year (YOY) growth.
- Record worldwide prodisc Cervical revenue of $14.7 million, on 38% YOY growth.
- Record U.S. prodisc Cervical revenue, on 43% YOY growth.
- Record U.S. prodisc total surgeon user-base of nearly 630 surgeons, representing almost 46% YOY growth and sequential quarterly user growth of 6%. Q3 2024 was the 9th consecutive quarter of surgeon user growth.
Highlights on the New prodisc C Vivo & prodisc C SK Cervical System
- Over 7,600 U.S. procedures have been completed with the new Match-the-Disc™ prodisc C Vivo and prodisc C SK Cervical System since limited release in Q3 2022.
- Record prodisc C Vivo revenue in Q3 2024, representing 55% YOY growth, and prodisc SK continuing sales momentum with 74% YOY growth.
- Record number of surgeons using the Match-the-Disc Cervical System in Q3 2024, increasing the total number of surgeons that have used the system by nearly 115% YOY and over 15% in sequential quarterly growth.
- Over 70% of the U.S. surgeons that have used the new system to date are repeat users, and a strong majority of surgeon users come from competitive conversions.
* Based on publicly available information.
M
M